GE HealthCare Technologies Inc.
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of GE HealthCare Technologies Inc. (GEHC). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| AIS | – | $3.49B 69.9% | – | $3.77B 71.3% |
| PDx | $632.0M 13.3% | $729.0M 14.6% | $770.0M 15.1% | $843.0M 15.9% |
| PCS | $753.0M 15.8% | $778.0M 15.6% | $704.0M 13.8% | $675.0M 12.8% |
| Imaging | $2.14B 44.9% | – | $2.30B 45.0% | – |
| AVS | $1.24B 26.0% | – | $1.34B 26.2% | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | Q1 2025 | Q2 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| Product | $3.12B 65.3% | $3.26B 65.2% | $3.35B 65.2% | $3.42B 64.5% |
| Service | $1.66B 34.7% | $1.74B 34.8% | $1.79B 34.8% | $1.88B 35.5% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.